Sep 25, 2018
Intec Pharma to Present Multiple Posters at International Congress of Parkinson's and Movement Disorder Society
Sep 20, 2018
Intec Pharma to Participate at Upcoming Investment Conferences
Jun 29, 2018
Intec Pharma Appoints William Bradley Hayes to Board of Directors
May 31, 2018
Intec Pharma to Present at Jefferies 2018 Healthcare Conference
May 15, 2018
Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update
Apr 24, 2018
Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting
Apr 13, 2018
Intec Pharma Announces Closing of $35.4 Million Public Offering of Ordinary Shares
Apr 11, 2018
Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares
Apr 10, 2018
Intec Pharma Announces Proposed Public Offering of Ordinary Shares
Apr 04, 2018
Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting
Apr 03, 2018
Intec Pharma Ltd. to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease
Mar 26, 2018
Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors
Mar 12, 2018
Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson's Disease
Mar 09, 2018
Intec Pharma Reports Fourth Quarter and Year End 2017 Financial Results and Business Update
Mar 05, 2018
Intec Pharma, Ltd. to Present at Four Investor Conferences in March
Jan 31, 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Jan 08, 2018
Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company
Jan 03, 2018
Intec Pharma Granted Patent in Canada for Accordion Pill(TM) Carbidopa / Levodopa
Nov 15, 2017
Intec Pharma Reports Third Quarter 2017 Operating and Financial Results
Nov 08, 2017
Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference